About Anavex Life Sciences Corporation - Company Information, Overview, History and Profile
What does Anavex Life Sciences Corporation do?
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.
Anavex Life Sciences Corporation Management structure
All Gross Remunerations are in USD
Dr. Christopher U. Missling, PhD
Director, President, Chief Executive Officer and Secretary
-
2024
Gross Remuneration
Year
Ms. Sandra Boenisch, C.G.A.,C.P.A.
Principal Financial Officer, Principal Accounting Officer and Treasurer
-
2024
Gross Remuneration
Year
Anavex Life Sciences Corporation Board of directors
All Gross Remunerations are in USD
Mr. Athanasios Skarpelos
Independent Director
-
2024
Gross Remuneration
Year
Dr. Christopher U. Missling, PhD
Director, President, Chief Executive Officer and S